TargetHistone-lysine N-methyltransferase 2A(Homo sapiens (Human))
China Pharmaceutical University
Curated by ChEMBL
China Pharmaceutical University
Curated by ChEMBL
Affinity DataKi: <1nMAssay Description:Inhibition of MLL1 binding to N-terminal His-tagged WRD5 23 deletion mutant (24 to 334 residues) (unknown origin) expressed in Escherichia coli Roset...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A(Homo sapiens (Human))
China Pharmaceutical University
Curated by ChEMBL
China Pharmaceutical University
Curated by ChEMBL
Affinity DataKi: <1nMAssay Description:Inhibition of MLL1 binding to N-terminal His-tagged WRD5 23 deletion mutant (24 to 334 residues) (unknown origin) expressed in Escherichia coli Roset...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A(Homo sapiens (Human))
China Pharmaceutical University
Curated by ChEMBL
China Pharmaceutical University
Curated by ChEMBL
Affinity DataKi: <1nMAssay Description:Inhibition of MLL1 binding to N-terminal His-tagged WRD5 23 deletion mutant (24 to 334 residues) (unknown origin) expressed in Escherichia coli Roset...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC
US Patent
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair